Clinical Trials
for Multiple Sclerosis in Washington
14 clinical trials for Multiple Sclerosis are currently recruiting participants at study sites in Washington. Study-related care is provided at no cost.
Multiple Sclerosis clinical trials in Washington: what to expect
Multiple sclerosis trials divide into relapsing and progressive forms. Relapsing MS studies test new oral and infused disease-modifying therapies, usually against an approved medicine rather than a placebo. Progressive MS has fewer approved options, so trials there test drugs meant to slow disability, protect nerves or repair myelin, and often do use a placebo. Alongside these are trials of rehabilitation, exercise, diet, fatigue and bladder treatments, and studies that simply follow people over time with MRI and blood tests.
In Washington, recruiting multiple sclerosis studies are concentrated in Seattle, Kirkland, Spokane and Kenmore. 9 of the 14 are run by a drug or device company, which usually means a larger study with travel reimbursement; the rest are academic or hospital-led.
Who multiple sclerosis trials usually look for
Listings state the type of MS, an age range (commonly 18 to 55 for relapsing trials, up to 65 for progressive) and a disability score range measured by the study neurologist. Relapsing trials usually want a relapse or new MRI activity in the past one to two years. Drug trials require a washout from your current therapy, which varies from weeks to months by drug and is managed by the site. Symptom and rehabilitation trials let you stay on your treatment.
What taking part involves
Screening includes a neurological exam, blood work and an MRI. Drug trials then run one to three years with visits every one to three months, an MRI every six to twelve months and a relapse assessment whenever symptoms change. Relapses are treated as normal. The study drug, scans and visits are free, and an extension usually lets everyone continue the active treatment afterwards. Rehabilitation trials involve sessions over eight to twenty-four weeks with walking, hand and cognition tests.
Questions worth asking the study team
What the comparison treatment is; how the washout from your current therapy is handled and how long it lasts; how many MRIs are needed; whether there is an extension; and what happens if you relapse during the study.
Showing 14 of 14 recruiting Multiple Sclerosis trials in Washington
Where the Multiple Sclerosis studies are in Washington
- TG Therapeutics Investigational Trial Site, Kirkland2 trials
- Bastyr University Clinical Research Center, Kenmore1 trial
- Citta Clinical Research, Spokane1 trial
- Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle1 trial
- EvergreenHealth Medical Center, Kirkland1 trial
- Fred Hutchinson Cancer Center, Seattle1 trial
Counts are recruiting studies listing at least one site in Washington, from ClinicalTrials.gov, refreshed every two days.
Multiple Sclerosis clinical trials in Washington: common questions
Check Your Eligibility
Create a free profile and our AI will match you to Multiple Sclerosis trials near you in Washington.
Get Matched — FreeMS trials investigate disease-modifying therapies, remyelination strategies, stem-cell transplants, and neuroprotective agents for relapsing and progressive forms of MS.
All Multiple Sclerosis trials →